SC

Steven Coffey

Kazia Therapeutics Limited | Non-Executive Director
Mr Coffey has over 35 years of experience in the accounting and finance industry. Steven is a business and tax consultant with Charternet, the chartered accounting firm that merged with his accounting practice, Watkins Coffey Martin in February 2022. He is a director and principal of BC Advisory & Accountancy Services Pty Limited, a boutique accounting, tax and advisory practice. He is a Chair of Risk and Governance Committee.

Company and Role

Company
Title
Tenure
Since
KZA
Kazia Therapeutics Limited
  • Non-Executive Director
11yrs, 7mthNov 2012

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
KZA
Kazia Therapeutics Limited
31/08/238,015983,978400,000N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
KZA
Kazia Therapeutics Limited
20/03/23
Buy
135,000$0.120$16,200Off-market trade
KZA
Kazia Therapeutics Limited
03/03/23
Buy
272,728$0.110$30,000Participation in share purchase plan
KZA
Kazia Therapeutics Limited
07/09/22
Buy
50,000$0.223$11,158On-market trade. Typing error in value consideration, http://www.aspecthuntley.com.au/asxdata/20230306/pdf/02640137.pdf
KZA
Kazia Therapeutics Limited
20/12/21
Buy
50,000$1.083$54,154On-market trade
KZA
Kazia Therapeutics Limited
02/06/21
Buy
8,000$1.246$9,968On-market trade